Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease

被引:27
|
作者
Li, Xiaoyan [1 ]
Wang, Hua [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Peoples R China
[2] Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China
来源
CELL AND BIOSCIENCE | 2020年 / 10卷 / 01期
关键词
Non-alcoholic fatty liver disease; Energy metabolism; Lipid; Hormone; Inter-organ crosstalk; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; GROWTH-FACTOR; 21; ENDOPLASMIC-RETICULUM STRESS; HEPATIC LIPID-METABOLISM; RECEPTOR-DEFICIENT MICE; INSULIN-RESISTANCE; GUT MICROBIOTA; ENERGY-METABOLISM; EXTRAHEPATIC COMPLICATIONS;
D O I
10.1186/s13578-020-00507-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) represents the leading cause of chronic liver disease worldwide and the anticipated health burden is huge. There are limited therapeutic approaches for NAFLD now. It's imperative to get a better understanding of the disease pathogenesis if new treatments are to be discovered. As the hepatic manifestation of metabolic syndrome, this disease involves complex interactions between different organs and regulatory pathways. It's increasingly clear that brain, gut and adipose tissue all contribute to NAFLD pathogenesis and development, in view of their roles in energy homeostasis. In the present review, we try to summarize currently available data regarding NAFLD pathogenesis and to lay a particular emphasis on the inter-organ crosstalk evidence.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease from pathogenesis to management: an update
    Musso, G.
    Gambino, R.
    Cassader, M.
    OBESITY REVIEWS, 2010, 11 (06) : 430 - 445
  • [32] Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
    Ma, Dae Won
    Ha, Joohun
    Yoon, Kyung Sik
    Kang, Insug
    Choi, Tae Gyu
    Kim, Sung Soo
    NUTRIENTS, 2023, 15 (09)
  • [33] The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
    Polyzos, Stergios A.
    Kountouras, Jannis
    Zavos, Christos
    Tsiaousi, Eleni
    DIABETES OBESITY & METABOLISM, 2010, 12 (05): : 365 - 383
  • [34] The role of B lymphocytes in the pathogenesis of non-alcoholic fatty liver disease
    Zhang, Feng
    Jiang, Weiwei
    Wu, Zhe
    Li, Xia
    Qiu, Xinyun
    Liu, Yulan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 328 - 328
  • [35] MicroRNAs as Mediators in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Steatohepatitis
    Becker, Philip P.
    Schmitt, Johannes
    Niesler, Beate
    Tschopp, Oliver
    Dandekar, Thomas
    Mullhaupt, Beat
    Geier, Andreas
    HEPATOLOGY, 2013, 58 : 554A - 554A
  • [36] Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review
    Torosian, Kelly
    Lal, Esha
    Kavanaugh, Arthur
    Loomba, Rohit
    Ajmera, Veeral
    Guma, Monica
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 59
  • [37] Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
    Adolph, Timon E.
    Grander, Christoph
    Grabherr, Felix
    Tilg, Herbert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [38] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [39] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [40] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224